| authorizations: |
registration not required
|
| accessURL: |
http://www.iedb.org/reference/696 |
| landingPage: |
http://www.iedb.org/assay/6972 |
| type: |
Literature
|
| publicationVenue: |
J Virol
|
| dates: |
2005
|
| study type: | b cell assays |
| subject species: | SARS coronavirus |
| fullName: |
Xiaofen Zhong
Huanghao Yang
Zu-Feng Guo
Wan-Yee Fion Sin
Wei Chen
Junjie Xu
Ling Fu
Jie Wu
Chun-Kit Gannon Mak
Chak-Sum Samuel Cheng
Yanzhen Yang
Shuyong Cao
Tin-Yau Wong
Sik-To Lai
Yong Xie
Zhihong Guo
|
| method: |
biological activity
|
| name: |
B-cell responses in patients who have recovered from severe acute respiratory syndrome target a dominant site in the S2 domain of the surface spike glycoprotein.
|
| description: |
This sequence is denoted by authors as an epitope-rich region encompassing an identified convergent region for antibody from convlescent sera of SARS-CoV patients who have recovered. The authors identified 5 peptides within this region and these peptidesfell into two distinct groups of peptides corresponding to two putatively distinct distinct epitopes. For experimental purposes the N-terminus of the synthetic peptide was N-acetylated.
Protection of SARS-CoV infection of Vero E6 cells was measured by addition of sera from convalescent patient J. Blocking of protection was demonstrated by pre-mixing sera with SL21 epitopic region.
|
| name: |
iedb
|
| homePage: |
http://www.iedb.org |